Analyst Conferences and Operating Report Tidbits
Executive Summary
Lilly advisory committees?: "We don't anticipate advisory committees" for the ADHD treatment atomoxetine, the antidepressant duloxetine or the erectile dysfunction agent Cialis (tadalafil), Lilly Exec VP-Pharmaceutical Products & Corporate Development John Lechleiter, PhD, told analysts at the Lehman Brothers Global Healthcare Conference in Orlando, Fla. Feb. 26....
You may also be interested in...
Tidbits From First Quarter Conference Calls, In Brief
GSK Wellbutrin SR generics: Difficulty in manufacturing Wellbutrin SR likely to stall generic competition for bupropion extended-release, GlaxoSmithKline CEO J.P. Garnier says April 30. "This product is not that easy to copy. In fact, the SR is a fraction easier; the XL is really tough." Blend uniformity problems have prevented approval of Andrx' ANDA; those issues are said to have been resolved (1"The Pink Sheet" July 15, 2002, p. 7)....Andrx bupropion delay: Andrx is "communicating" with FDA regarding a specification change that affects expiration dating of its Wellbutrin SR generic, CEO Richard Lane says April 30. "Since learning of this issue, we have worked diligently to remedy the situation," he says. "We are unable to predict when and if this issue will be resolved satisfactorily and these products launched." Andrx is also awaiting D.C. court decision on GSK's appeal of non-infringement ruling (2"The Pink Sheet" Dec. 9, 2002, p. 28)....
Tidbits From First Quarter Conference Calls, In Brief
GSK Wellbutrin SR generics: Difficulty in manufacturing Wellbutrin SR likely to stall generic competition for bupropion extended-release, GlaxoSmithKline CEO J.P. Garnier says April 30. "This product is not that easy to copy. In fact, the SR is a fraction easier; the XL is really tough." Blend uniformity problems have prevented approval of Andrx' ANDA; those issues are said to have been resolved (1"The Pink Sheet" July 15, 2002, p. 7)....Andrx bupropion delay: Andrx is "communicating" with FDA regarding a specification change that affects expiration dating of its Wellbutrin SR generic, CEO Richard Lane says April 30. "Since learning of this issue, we have worked diligently to remedy the situation," he says. "We are unable to predict when and if this issue will be resolved satisfactorily and these products launched." Andrx is also awaiting D.C. court decision on GSK's appeal of non-infringement ruling (2"The Pink Sheet" Dec. 9, 2002, p. 28)....
Lilly Focuses Xigris Promotion On Physician “Peer-To-Peer” Discussions
Lilly believes "peer-to-peer" discussions about positive experiences with Xigris will energize sales of the sepsis agent, Exec VP-Pharmaceutical Products & Corporate Development John Lechleiter, PhD, said